|
| 37871132 | Toward Explainable Artificial Intelligence for Precision Pathology. | Annu Rev Pathol | 2024 |
| 36349502 | Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, EMT nor metastatic spread in colorectal cancer. | J Pathol Clin Res | 2023 |
| 37594677 | A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich. | Target Oncol | 2023 |
| 37548948 | [Testing deficient mismatch repair and microsatellite instability : AÂ focused update. German version]. | Pathologie (Heidelb) | 2023 |
| 37544709 | Tumour mutational burden and survival with molecularly matched therapy. | Eur J Cancer | 2023 |
| 37542550 | Implementing precision oncology for sarcoma patients: the CCC<sup>LMU</sup>molecular tumor board experience. | J Cancer Res Clin Oncol | 2023 |
| 37874379 | Testing for deficient mismatch repair and microsatellite instability : AÂ focused update. | Pathologie (Heidelb) | 2023 |
| 37641393 | Precision cancer medicine: Concepts, current practice, and future developments. | J Intern Med | 2023 |
| 38034041 | Evaluation of the effectiveness of a nationwide precision medicine program for patients with advanced non-small cell lung cancer in Germany: a historical cohort analysis. | Lancet Reg Health Eur | 2023 |
| 35796778 | Lessons learned: the first consecutive 1000 patients of the CCCMunich<sup>LMU</sup> Molecular Tumor Board. | J Cancer Res Clin Oncol | 2023 |
| 35796776 | Immuno-histochemical correlation of fibrosis-related markers with the desmoplastic reaction of the mesentery in small intestine neuroendocrine neoplasms. | J Cancer Res Clin Oncol | 2023 |
| 37345075 | TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS). | Cancers (Basel) | 2023 |
| 37080557 | Creation of a structured molecular genomics report for Germany as a local adaption of HL7's Genomic Reporting Implementation Guide. | J Am Med Inform Assoc | 2023 |
| 37076398 | Intratumoral Heterogeneity of Molecular Subtypes in Muscle-invasive Bladder Cancer-An Extensive Multiregional Immunohistochemical Analysis. | Eur Urol Focus | 2023 |
| 37369037 | Do skip-N2 metastases significantly impact overall survival and disease-free interval in N2 non-small-cell lung cancer patients? A multicentre analysis. | Eur J Cardiothorac Surg | 2023 |
| 37062035 | Cancer of unknown primary (CUP) through the lens of precision oncology: a single institution perspective. | J Cancer Res Clin Oncol | 2023 |
| 36519297 | Analysing cerebrospinal fluid with explainable deep learning: From diagnostics to insights. | Neuropathol Appl Neurobiol | 2023 |
| 36853374 | Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunich<sup>LMU</sup> Molecular Tumor Board. | Target Oncol | 2023 |
| 36748436 | The other colon cancer: a population-based cohort study of appendix tumour trends and prognosis. | Colorectal Dis | 2023 |
| 36401637 | Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance. | J Cancer Res Clin Oncol | 2023 |
| 36935856 | DNA-methylation and genomic copy number in primary tumors and corresponding lymph node metastases in prostate cancer from patients with low and high Gleason score. | Clin Transl Radiat Oncol | 2023 |
| 36735063 | Structure and content of the EU-IVDR : Current status and implications for pathology. | Pathologie (Heidelb) | 2023 |
| 36629274 | Single-cell gene regulatory network prediction by explainable AI. | Nucleic Acids Res | 2023 |
| 34564861 | Mucosal melanomas of different anatomic sites share a common global DNA methylation profile with cutaneous melanoma but show location-dependent patterns of genetic and epigenetic alterations. | J Pathol | 2022 |
| 35647009 | Diagnostic Accuracy of Magnetic Resonance Enterography for the Evaluation of Active and Fibrotic Inflammation in Crohn's Disease. | Front Surg | 2022 |
| 35646657 | Liquid Biopsy in Colorectal Cancer: Quo Vadis? Implementation of Liquid Biopsies in Routine Clinical Patient Care in Two German Comprehensive Cancer Centers. | Front Oncol | 2022 |
| 35403871 | [Artificial intelligence: a solution for the lack of pathologists?] | Pathologe | 2022 |
| 35672443 | Patient-level proteomic network prediction by explainable artificial intelligence. | NPJ Precis Oncol | 2022 |
| 35642679 | Correction to "Integration of Metabolomics and Expression of Glycerol-3-phosphate Acyltransferase (GPAM) in Breast Cancerâ¿¿Link to Patient Survival, Hormone Receptor Status, and Metabolic Profiling". | J Proteome Res | 2022 |
| 35728978 | Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages. | Eur Respir J | 2022 |
| 35576834 | AURKA is a prognostic biomarker for good overall survival in stage II colorectal cancer patients. | Pathol Res Pract | 2022 |
| 35763870 | Gene expression-based prediction of pazopanib efficacy in sarcoma. | Eur J Cancer | 2022 |
| 35366396 | Type 1 conventional dendritic cells maintain and guide the differentiation of precursors of exhausted TÂ cells in distinct cellular niches. | Immunity | 2022 |
| 35569281 | Biomarker-driven therapies for metastatic uveal melanoma: A prospective precision oncology feasibility study. | Eur J Cancer | 2022 |
| 35749951 | DNA methylation-based machine learning classification distinguishes pleural mesothelioma from chronic pleuritis, pleural carcinosis, and pleomorphic lung carcinomas. | Lung Cancer | 2022 |
| 36443295 | DNA methylation-based classification of sinonasal tumors. | Nat Commun | 2022 |
| 36544698 | Isolation and characterization of head and neck cancer-derived peritumoral and cancer-associated fibroblasts. | Front Oncol | 2022 |
| 36045222 | Simultaneous metabolite MALDI-MSI, whole exome and transcriptome analysis from formalin-fixed paraffin-embedded tissue sections. | Lab Invest | 2022 |
| 36135637 | Deep Learning Assisted Diagnosis of Onychomycosis on Whole-Slide Images. | J Fungi (Basel) | 2022 |
| 35901081 | Carbonic anhydrase XII as biomarker and therapeutic target in ovarian carcinomas. | PLoS One | 2022 |
| 35958344 | Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol for a prospective longitudinal biomarker study. | Transl Lung Cancer Res | 2022 |
| 35955851 | Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World Setting. | Int J Mol Sci | 2022 |
| 35892888 | Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEAL. | Cancers (Basel) | 2022 |
| 35925306 | [Structure and content of the EU-IVDR : Current status and implications for pathology]. | Pathologie (Heidelb) | 2022 |
| 35983950 | Bcl-x<sub>L</sub> as prognostic marker and potential therapeutic target in cholangiocarcinoma. | Liver Int | 2022 |
| 36347879 | New definitions of human lymphoid and follicular cell entities in lymphatic tissue by machine learning. | Sci Rep | 2022 |
| 36191385 | DeepClassPathway: Molecular pathway aware classification using explainable deep learning. | Eur J Cancer | 2022 |
| 36219392 | SMAD4 Loss Induces c-MYC-Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis. | Cancer Res | 2022 |
| 33631297 | Artificial intelligence and pathology: From principles to practice and future applications in histomorphology and molecular profiling. | Semin Cancer Biol | 2022 |
| 35185017 | A combination of immunohistochemical markers, MUC1, MUC5AC, PAX8 and growth pattern for characterization of mucinous neoplasm of the ovary. | Int J Gynecol Cancer | 2022 |